Highlights
- 1
- 2
- 3
Publications
81 publications
Funding
2 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPIR01AG096902-01CH25H mediates microglial neuroinflammation and tau toxicities in ADNational Institute on Aging · 2025–2030
- Co-IRF1AG079557-01Elucidate the Roles of Alzheimer's Disease Variants in Gene Expression and AD PhenotypesNational Institute on Aging · 2022–2027 · via The Regents of the University of California, San Francisco
Available technologies
1 technologyView full WCM portfolio ↗
- Inhibition of the UFMylation Cascade for Treatment of Alzheimer's Disease and 4R Tauopathies10763Provisional filedPoC DataPMID 38582079
News mentions
1 mentionView all WCM news ↗
- Human Neuron Model Paves the Way for New Alzheimer’s TherapiesApril 5, 2024
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia.